These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3890575)

  • 41. Chemotherapy of the drug-resistant malarias.
    Schmidt LH
    Annu Rev Microbiol; 1969; 23():427-54. PubMed ID: 4901983
    [No Abstract]   [Full Text] [Related]  

  • 42. Cure of vivax malaria.
    Med Lett Drugs Ther; 1968 May; 10(11):44. PubMed ID: 4872214
    [No Abstract]   [Full Text] [Related]  

  • 43. Chloroquine-resistant falciparum malaria from East Africa.
    Bhattacharya DN; Hall AP
    J Trop Med Hyg; 1986 Dec; 89(6):291-4. PubMed ID: 3543385
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Curative treatment of malaria Plasmodium falciparum, P. vivax and P. ovale malaria with mefloquine].
    Danis M; Felix H; Brucker G; Druilhe P; Datry A; Richard-Lenoble D; Gentilini M
    Med Trop (Mars); 1982; 42(4):427-32. PubMed ID: 6755143
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of treatment schedules for Plasmodium vivax infections in the Solomon Islands.
    Saint-Yves IF
    P N G Med J; 1977 Jun; 20(2):62-5. PubMed ID: 339599
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of malaria with a combination of 3 drugs on the Island of São Luis, Maranhão, Brazil].
    Melo JE
    Rev Bras Malariol Doencas Trop; 1981; 33():75-85. PubMed ID: 6760262
    [No Abstract]   [Full Text] [Related]  

  • 47. CYP2D6 activity and the risk of recurrence of Plasmodium vivax malaria in the Brazilian Amazon: a prospective cohort study.
    Brasil LW; Rodrigues-Soares F; Santoro AB; Almeida ACG; Kühn A; Ramasawmy R; Lacerda MVG; Monteiro WM; Suarez-Kurtz G
    Malar J; 2018 Feb; 17(1):57. PubMed ID: 29390987
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.
    Llanos-Cuentas A; Lacerda MV; Rueangweerayut R; Krudsood S; Gupta SK; Kochar SK; Arthur P; Chuenchom N; Möhrle JJ; Duparc S; Ugwuegbulam C; Kleim JP; Carter N; Green JA; Kellam L
    Lancet; 2014 Mar; 383(9922):1049-58. PubMed ID: 24360369
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radical cure of Chesson strain vivax malaria in man by 7, not 14, days of treatment with primaquine.
    Clyde DF; McCarthy VC
    Am J Trop Med Hyg; 1977 May; 26(3):562-3. PubMed ID: 326072
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Short report: primaquine-tolerant Plasmodium vivax in an Italian traveler from Guatemala.
    Signorini L; Matteelli A; Castelnuovo F; Castelli F; Oladeji O; Carosi G
    Am J Trop Med Hyg; 1996 Nov; 55(5):472-3. PubMed ID: 8940974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia.
    Maguire JD; Krisin ; Marwoto H; Richie TL; Fryauff DJ; Baird JK
    Clin Infect Dis; 2006 Apr; 42(8):1067-72. PubMed ID: 16575721
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The sporogonous of Plasmodium vivax in Anopheles mosquitoes as a system for evaluating the prophylactic and curative capabilities of potential antimalarial compounds.
    Terzian LA; Stahler N; Dawkins AT
    Exp Parasitol; 1968 Aug; 23(1):56-66. PubMed ID: 4876903
    [No Abstract]   [Full Text] [Related]  

  • 53. A phase II clinical trial of mefloquine in Brazilian male subjects.
    de Souza JM
    Bull World Health Organ; 1983; 61(5):815-20. PubMed ID: 6360401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primaquine as prophylaxis for malaria for nonimmune travelers: A comparison with mefloquine and doxycycline.
    Schwartz E; Regev-Yochay G
    Clin Infect Dis; 1999 Dec; 29(6):1502-6. PubMed ID: 10585803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chloroquine-resistant Plasmodium vivax.
    Whitby M; Wood G; Veenendaal JR; Rieckmann K
    Lancet; 1989 Dec; 2(8676):1395. PubMed ID: 2574333
    [No Abstract]   [Full Text] [Related]  

  • 56. Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in northeastern Myanmar.
    Yuan L; Wang Y; Parker DM; Gupta B; Yang Z; Liu H; Fan Q; Cao Y; Xiao Y; Lee MC; Zhou G; Yan G; Baird JK; Cui L
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1230-5. PubMed ID: 25512415
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A phase I clinical trial of mefloquine in Brazilian male subjects.
    de Souza JM
    Bull World Health Organ; 1983; 61(5):809-14. PubMed ID: 6360400
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
    Walsh DS; Wilairatana P; Tang DB; Heppner DG; Brewer TG; Krudsood S; Silachamroon U; Phumratanaprapin W; Siriyanonda D; Looareesuwan S
    Clin Infect Dis; 2004 Oct; 39(8):1095-103. PubMed ID: 15486831
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma and whole blood mefloquine concentrations during treatment of chloroquine-resistant falciparum malaria with the combination mefloquine-sulphadoxine-pyrimethamine.
    Karbwang J; Looareesuwan S; Phillips RE; Wattanagoon Y; Molyneux ME; Nagachinta B; Back DJ; Warrell DA
    Br J Clin Pharmacol; 1987 Apr; 23(4):477-81. PubMed ID: 3555581
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The prevention and treatment of malaria.
    Black RH
    Med J Aust; 1977 Jun; 1(25):929-33. PubMed ID: 329080
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.